Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation
- 1 February 2013
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 304 (3) , C273-C279
Abstract
Several studies have implicated the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in inhibition of normal platelet function, suggesting a role for platelets in EPA- and DHA-mediated cardioprotection. However, it is unclear whether the cardioprotective mechanisms arise from alterations to platelet-platelet, platelet-matrix, or platelet-coagulation factor interactions. Our previous results led us to hypothesize that EPA and DHA alter the ability of platelets to catalyze the generation of thrombin. We tested this hypothesis by exogenously modifying platelet membranes with EPA and DHA, which resulted in compositional changes analogous to increased dietary EPA and DHA intake. Platelets treated with EPA and DHA showed reductions in the rate of thrombin generation and exposure of platelet phosphatidylserine. In addition, treatment of platelets with EPA and DHA decreased thrombus formation and altered the processing of thrombin precursor proteins. Furthermore, treatment of whole blood with EPA and DHA resulted in increased occlusion time and a sharply reduced accumulation of fibrin under flow conditions. These results demonstrate that EPA and DHA inhibit, but do not eliminate, the ability of platelets to catalyze thrombin generation in vitro. The ability of EPA and DHA to reduce the procoagulant function of platelets provides a possible mechanism behind the cardioprotective phenotype in individuals consuming high levels of EPA and DHA.Keywords
This publication has 35 references indexed in Scilit:
- Membrane Binding Events in the Initiation and Propagation Phases of Tissue Factor-initiated Zymogen Activation under FlowJournal of Biological Chemistry, 2012
- Omega-3 Fatty Acids and Cardiovascular DiseaseJACC, 2011
- Activated factor XI inhibits chemotaxis of polymorphonuclear leukocytesJournal of Leukocyte Biology, 2011
- n–3 Fatty Acids in Cardiovascular DiseaseNew England Journal of Medicine, 2011
- Omega-3 fatty acids modulate collagen signaling in human plateletsProstaglandins, Leukotrienes and Essential Fatty Acids, 2011
- Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activityBlood, 2011
- Resolvin E1 Regulates Adenosine Diphosphate Activation of Human PlateletsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Anucleate platelets generate progenyBlood, 2010
- Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and plateletsBlood, 2008
- Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjectsThrombosis and Haemostasis, 2008